{
  "trial_id": "NCT01427920",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Gender, Duration of Type 2 Diabetes, Baseline HbA1c, Body Mass Index (BMI), Baseline Metformin Dose, Baseline Fasting Plasma Glucose, Baseline Self-Measured Plasma Glucose (SMPG) Frequency, Baseline Insulin Dose, Baseline Blood Pressure, Baseline Alanine Aminotransferase (ALAT) Levels, Baseline Serum Creatinine Levels, Region (Asia, Europe, South America)",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Gender",
          "Gender"
        ],
        [
          "Body Mass Index",
          "Body Mass Index (BMI)"
        ],
        [
          "Glycosylated Haemoglobin (HbA1c)",
          "Baseline HbA1c"
        ],
        [
          "Fasting Plasma Glucose",
          "Baseline Fasting Plasma Glucose"
        ]
      ],
      "remaining_reference_features": [
        "Body Weight"
      ],
      "remaining_candidate_features": [
        "Duration of Type 2 Diabetes",
        "Baseline Metformin Dose",
        "Baseline Self-Measured Plasma Glucose (SMPG) Frequency",
        "Baseline Insulin Dose",
        "Baseline Blood Pressure",
        "Baseline Alanine Aminotransferase (ALAT) Levels",
        "Baseline Serum Creatinine Levels",
        "Region (Asia, Europe, South America)"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, Baseline HbA1c, Body Mass Index, Daily Insulin Dose, Systolic Blood Pressure, Diastolic Blood Pressure, Serum Creatinine, Alanine Aminotransferase (ALAT),",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Gender",
          "Sex: Female"
        ],
        [
          "Body Mass Index",
          "Body Mass Index"
        ],
        [
          "Glycosylated Haemoglobin (HbA1c)",
          "Baseline HbA1c"
        ],
        [
          "Systolic Blood Pressure",
          "Systolic Blood Pressure"
        ],
        [
          "Diastolic Blood Pressure",
          "Diastolic Blood Pressure"
        ],
        [
          "Serum Creatinine",
          "Serum Creatinine"
        ],
        [
          "Alanine Aminotransferase (ALAT)",
          "Alanine Aminotransferase (ALAT)"
        ]
      ],
      "remaining_reference_features": [
        "Body Weight",
        "Fasting Plasma Glucose"
      ],
      "remaining_candidate_features": [
        "Male",
        "Race/Ethnicity",
        "Region of Enrollment",
        "Duration of Diabetes",
        "Daily Insulin Dose"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Region of Enrollment, Diabetes Duration, Body Mass Index, HbA1c, Systolic Blood Pressure, Diastolic Blood Pressure, Total Daily Dose of Metformin, Previous Insulin Treatment.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Body Mass Index",
          "Body Mass Index"
        ],
        [
          "Glycosylated Haemoglobin (HbA1c)",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Gender",
        "Body Weight",
        "Fasting Plasma Glucose"
      ],
      "remaining_candidate_features": [
        "Sex: Female",
        "Male",
        "Region of Enrollment",
        "Diabetes Duration",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Total Daily Dose of Metformin",
        "Previous Insulin Treatment"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, BMI, duration of diabetes, type of diabetes treatment at screening, HbA1c at screening, fasting plasma glucose at screening, systolic and diastolic blood pressure, total daily dose of metformin, use of additional OAD treatment, history of cardiac problems, history of severe hypertension.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Gender",
          "sex"
        ],
        [
          "Body Mass Index",
          "BMI"
        ],
        [
          "Glycosylated Haemoglobin (HbA1c)",
          "HbA1c at screening"
        ],
        [
          "Fasting Plasma Glucose",
          "fasting plasma glucose at screening"
        ]
      ],
      "remaining_reference_features": [
        "Body Weight"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "duration of diabetes",
        "type of diabetes treatment at screening",
        "systolic and diastolic blood pressure",
        "total daily dose of metformin",
        "use of additional OAD treatment",
        "history of cardiac problems",
        "history of severe hypertension"
      ]
    }
  }
}